SCHEMBL23643965

SCHEMBL23643965

C=C(C/C(N)=C\C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20216144 0.65 — —
SCHEMBL12891027 0.64 — —
SCHEMBL21956005 0.63 ALDH1A1 (0.44) —
SCHEMBL20690142 0.63 — —
SCHEMBL21147075 0.63 — —
SCHEMBL13799172 0.63 TET2 (0.34) —
SCHEMBL19117753 0.63 — —
SCHEMBL22763470 0.62 TDP1 (0.36) —
SCHEMBL25122093 0.62 — —
SCHEMBL19144497 0.62 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214362-A1 FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE AKARNA THERAPEUTICS, LTD. (GB) 2021-07-15 — — US disclosed
Send feedback